ABSTRACT
triggered by a variety of genetic and environmental factors with the goal of finding bacterial 23 taxonomic groups that can act as signatures of health or disease across studies, and that can be 24 used to discriminate between healthy and diseased mice. We leveraged recent developments in 25 16S analysis tools to identify amplicon sequence variants (ASVs) instead of the traditional 26 Operational Taxonomic Units, and used the EZTaxon reference database that distinguishes 27 between currently unnamed and uncharacterized 16S phylotypes. Random Forest model and 28 differential abundance analysis were used to detect microbial signatures that could consistently 29 differentiate healthy from diseased mice, and a 'dysbiosis index' was constructed from these. 30 This dysbiosis index was able to correctly distinguish samples derived from inflamed and non-31 inflamed mice in the majority of studies and significantly outperformed other frequently used 32 metrics of dysbiosis including alpha-diversity, proteobacterial abundance, and the ratio of 33 Bacteroidetes to Firmicutes. 10 of 12 bacteria we identify as associated with the diseased state
INTRODUCTION

38
The human gut contains vast numbers of bacteria, viruses and fungi that collectively 39 make up the gut microbiota, which plays a pivotal role in the host's health (1) . While the 40 microbiome is important for fundamental host processes like digestion (2), metabolism (3) and immune system development (4), changes in the microbiome, often termed dysbioses (5), have reproducibility and well-defined conditions, murine samples also seem to have significant inter-individual variability, lack of standardization across studies, and sample sizes are often small 66 (14, 16) . Furthermore, there are multiple widely-used mouse models for IBD, including Dextran 67 Sodium Sulfate (DSS) induced colitis, 2,4,6-trinitrobenzenesulfonic acid (TNBS) induced colitis, 68 T-cell adoptive transfer, and Interleukin-10 deficiency (17, 18) . Studies investigating the role of 69 various immunomodulatory genes in IBD also often report changes in the microbiota (19, 20) . 70 The existing literature mostly consists of descriptions of microbiota changes associated 71 with colitis in various mice models (19, 21, 22) , with only some assessing colitogenic potential 72 of particular microbiotas, or honing in on particular microbes (23, 24) . The lack of 73 standardization prevents meaningful comparison of the changes reported, and the question 74 remains as to whether there are any consistent markers of inflammation in mice models. Reviews 75 published have been descriptive (25, 26) . Since there is little overlap between the human and 76 murine microbiota, host-specific analysis is paramount (27) . In the context of a poorly 77 catalogued murine microbiota with limited cultured isolates (28), identification of a microbial 78 signature can help focus isolation efforts and mechanistic studies on the best microbial 79 candidates for further research in mouse models. 80 Here we report a meta-analysis of 12 studies/datasets that utilize 16S sequencing to 81 describe a link between development of colitis and changes in the microbiota in murine models. 82 We aimed to find bacterial taxonomic groups that are consistent signatures of health and disease 83 across studies, and that can be used to discriminate between healthy and diseased mice. We only 84 included studies whose raw 16S sequencing read files were available and thus were able to 85 standardize the analysis and directly compare the studies. We leveraged recent developments in 86 and samples administered antibiotics as these are likely to have changes that go well beyond 111 colitis associated ones. Studies that only assessed microbiota before inflammation onset were 112 excluded because we were interested in a microbial signature associated with the onset of colitis, 113 rather than a microbiota that is associated with increased susceptibility to colitis. coordinates suggested that samples tended to cluster by study more than by disease status (Fig   129   2a, b) . However, a Permutational Analysis of Variance (PERMANOVA) (42) suggested that 130 microbiome composition differed by both disease status and study (p < 0.001). Furthermore, 131 within each study, PERMANOVA revealed significant differences due to disease status in all 132 except one study (Fig S1) . Visually, within each study, disease status often provided a stark differentiation in PCoA plots, which was not replicated in the pooled data. However, the 134 significant PERMANOVA result suggested the possibility of differences between communities 135 based on disease status, across studies.
137
Alpha Diversity
138
Alpha diversity, the diversity of the microbiome within each sample, is regularly 139 investigated as a marker of "health" in both human and mouse studies. While individual studies 140 have found associations between reduced alpha diversity and obesity and IBD in humans, meta-141 analyses have found the evidence for such relationships to be weak (13, 43) . 142 yet inconsistent, within-sample marker is the ratio of Bacteroidetes to Firmicutes ratio. Lastly, a 143 bloom of Proteobacteria has also been associated with dysbiosis. We investigated the utility of 144 using these markers in discriminating between healthy and diseased mice.
145
In our meta-analysis, we do not find a consistent relationship between alpha diversity and 146 colitis in mice. Seven of the 11 studies had significant differences in the Shannon index (H) 147 between healthy and diseased mice, with 5 having higher values of H (lower diversity) in 148 healthy, and 2 having higher diversity in healthy (Fig 3a) . Similarly, there was no consistent 149 relationship between colitis and the Bacteroidetes to Firmicutes ratio; 2 studies had a 150 significantly lower ratio in healthy, while 2 had a significantly higher ratio in healthy (Fig 3b) . 151 Finally, there was also no consistent relationships between disease status and the relative 152 abundance of Proteobacteria (Fig 3c) . For all three measures, the pooled data did not show a 153 significant difference between the healthy and diseased mice when tested using random effects 154 models (p > 0.05).
155
Random Forest Models
Given the significant PERMANOVA results, inconsistent alpha diversity metrics, and the 158 success of statistical learning techniques in previous studies, we hypothesized that a random 159 forest model would be able to discriminate between diseased and healthy mice (12, 43, 44 (Fig 4a) .
170
To test the generalizability of this approach and whether the individual studies 171 contributed complementary or unique information, we conducted a leave-one-out analysis. One 172 by one, each study was left out, and the samples left out were predicted using a random forest 173 classifier trained on the remaining set of samples ("n-1"). Furthermore, we assessed the cross-174 validated performance of the "n-1" classifiers, as well as that of models trained on the study left 175 out and tested on the "n-1" set. The performance of the models varied greatly depending on 176 which study was left out, as measured by the AUROC (Fig 4b) Table 1 ). Ninety-eight of these had a higher mean abundance in mice 200 with colitis (colitis-associated taxons), while 86 had a higher mean abundance in healthy mice 274 We note that one study chosen (Whitfield-Cargile) was a distinct outlier in our analysis 275 from the other eleven studies. Unlike the other genetic and chemical models of dysbiosis 276 included in this meta-analysis, the NSAID-induced inflammation in the Whitfield-Cargile study 277 largely manifests in the distal jejunum and ileum and less the large intestine (i.e. it is not a true 278 "colitis" per se). Furthermore, the trigger of dysbiosis used in that study, the NSAID 279 indomethacin, is itself an anti-inflammatory agent that inhibits cyclooxygenase enzymes -which 280 would further change the nature of the resulting inflammation. This indicates that care must be 281 taken when comparing studies that may be superficially similar, but that have important 282 differences in their underlying mechanisms or locations within the host. Accordingly, we 283 believe the fact that the Whitfield-Cargile study performed differently than the other studies, 284 indicates that the dysbiosis index derived from our meta-analysis is robust and able to distinguish 285 colitis from other types of intestinal pathology. 286 The vast differences in the composition of the human and murine microbiota mean that 287 translation between the two cannot be made directly in terms of individual microbes. On one 288 hand, this means that it might require considerable effort in order to find any potential human 289 counterpart of murine microbes causally implicated in colitis. On the other hand, this has meant 290 that efforts to catalog the human gut microbiome has not helped much with cataloging the 291 murine microbiome and robust human meta-analyses to synthesize evidence on the IBD-In this context, the meta-analysis of animal studies can be useful. Generally, such studies are 294 conducted for preclinical animal trials to select robust candidates for clinical trials, and prevent 295 excessive replication (49, 50). However, animal meta-analyses can also play a valuable role in 296 guiding research avenues in murine models of complex systems like microbiomes that are often 297 studied at a macro-level, without a systematic approach to investigating host-microbe or 298 microbe-microbe interactions at a micro level. In our meta-analysis, we find that simple metrics 299 to summarize microbial diversity and composition may not be consistent; we also identify a 300 microbial signature of disease that is relatively robust across studies, and report a list of microbes 301 that may be good candidates for focused isolation and characterization efforts. Finally, our experience suggests that trying to standardize microbiome studies and make 311 the data publicly accessible is of paramount importance. One of the main time-consuming steps 312 in our analysis was the custom processing of datasets generated by a diversity of sequencing 313 approaches, and the resolution of our taxonomic classification was limited by the diversity of 314 16S primers used. While we identified 44 studies of interest for the meta-analysis, we were only 315 able to obtain data from 12, suggesting that only a small fraction of published sequencing data is actually deposited in a publicly accessible system. Journal policies on data-sharing can help 317 rectify this. Seventy-nine full-text articles were then assessed, and 44 were retained to be checked for 336 data availability. Ten studies had read files accessible in Sequence Read Archive, European 337 Nucleotide Archive, MG-RAST or personal collaboration; 32 studies had no publicly available 338 data or metadata, and only two provided access to data by the time of publication after contact.
Studies were excluded if they: did not do a 16S sequence-based analysis of the microbiome; used 340 a synthetic microbiota (e.g. Altered Schaedler Flora, humanized); only had outcomes of low-341 grade inflammation or aging associated "inflammaging"; used pathogenic infection for 342 inflammation; used bacterial treatment (e.g. probiotics); used antibiotic treatment; used non-343 murine models; did not have an outcome of colonic inflammation; did not have non-colitis 344 controls; was not a primary article; or that failed to assess the microbiota before onset of 345 inflammation. We had the final exclusion criteria because many studies aim to answer the 346 question of whether a particular microbiota is associated with increased susceptibility to colitis; 347 however, we were interested in a microbial signature associated with the onset of colitis. We 348 retained articles if they contained a subset of samples that were eligible, contingent on non-349 colitis controls being present. Within the included studies, we excluded any samples that met 350 relevant exclusion criteria outlined above (e.g. low-grade inflammation, antibiotic treatment).
352
Data Processing
353
For each study, we used a standardized bioinformatics pipeline to generate counts for 354 taxonomic groups. Quality filtering criteria was determined on a study-by-study basis depending 355 on the sequencing platform used and inspection of read quality (52, 53). Reads were filtered and 356 resolved to amplicon sequence variants (ASVs) using the DADA2 pipeline. The advantage of 357 using DADA2 over traditional clustering methods is that it resolves differences of as little as one 358 nucleotide to determine exact sequences based on an error model for the sequencing run (54).
359
Resolved paired-end sequences were merged where applicable, chimeras removed and a RSV-360 abundance tables built (equivalent to OTU-tables).
RSVs were assigned microbial taxonomies using a custom R script (55 
Random Forest Models
389
A random forest (RF) model was built with the pooled data using the caret package (60) 390 (10-fold cross validated, repeated 5 times; 250 trees), and area under the receiver operating 391 characteristic curve (AUROC) was sued to assess model performance in discriminating healthy 392 from diseased mice. To investigate the generalizability of using RF models, we conducted a 393 leave-one-out analysis, repeatedly building models on data from n-1 studies, and testing model 394 performance in predicting the study left out, using AUROC. To identify which taxonomic groups are most important in discriminating between 398 healthy and diseased mice within a random forest framework, the Boruta feature selection 399 algorithm was used with 500 runs using the Boruta package (46). Next, the selected taxa were 400 labelled as being associated with healthy or diseased status based on whether they had higher 401 mean abundance in healthy or diseased mice, respectively (statistical significance not 402 considered). This labelled list was pruned to contain only taxa present in 50% of diseased or 403 healthy mice. The dysbiosis index was calculated by log transforming the ratio of the colitis-404 associated taxa to the health-associated taxa.
As with the alpha diversity metrics, within each study, t-tests were used to determine the 406 utility of the index in discriminating between healthy and diseased mice, and a similar random 407 effects model was used for the pooled data.
408
All data was visualized using the ggplot2 package (61). 2 Thirty-three taxa selected through Boruta feature selection for inclusion in dysbiosis index. The median importance is the median importance score calculated by the Boruta algorithm. EZTaxon ID refer to the ID number in the EZTaxon database. Proporotion present refers to the proportion of healthy or colitis samples the taxon was present in.
